CANNAPHARMARX, INC. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
CANNAPHARMARX, INC. (CPMD) reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$382.02 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-20.
Financial Statements › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2026-05-20
- CANNAPHARMARX, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2026-03-31 was -$382.02K.
- CANNAPHARMARX, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-12-31 was -$7.55M.
- CANNAPHARMARX, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-09-30 was -$1.48M, a 884.31% decline year-over-year.
- CANNAPHARMARX, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-06-30 was -$1.41M, a 126.36% decline year-over-year.
- CANNAPHARMARX, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2025 was -$11.13M.
- CANNAPHARMARX, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2024 was -$9.91M, a 368.56% decline from fiscal 2023.
- CANNAPHARMARX, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2023 was $3.69M.
- CANNAPHARMARX, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2021 was -$8.83M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month as first filed | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|---|
| 2026-03-31 | -$382.02K 10-Q · filed 2026-05-20 | -$7.93M derived: sum of 2 quarters · filed 2026-05-20 | -$9.41M derived: sum of 3 quarters · filed 2026-05-20 | -$10.82M derived: sum of 4 quarters · filed 2026-05-20 | |
| 2025-12-31 | -$7.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$9.03M derived: sum of 2 quarters · filed 2026-03-31 | -$10.44M derived: sum of 3 quarters · filed 2026-03-31 | -$11.13M 10-K · filed 2026-03-31 | |
| 2025-09-30 | -$1.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$2.89M derived: sum of 2 quarters · filed 2025-11-14 | -$3.58M 10-Q · filed 2025-11-14 | -$7.32M derived: sum of 4 quarters · filed 2026-05-20 | |
| 2025-06-30 | -$1.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$2.10M 10-Q · filed 2025-08-14 | -$5.84M derived: sum of 3 quarters · filed 2026-05-20 | -$5.66M derived: sum of 4 quarters · filed 2026-05-20 | |
| 2025-03-31 | -$690.59K 10-Q · filed 2026-05-20 | -$4.43M derived: sum of 2 quarters · filed 2026-05-20 | -$4.24M derived: sum of 3 quarters · filed 2026-05-20 | $1.12M derived: sum of 4 quarters · filed 2026-05-20 | |
| 2024-12-31 | -$3.74M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$3.55M derived: sum of 2 quarters · filed 2026-03-31 | $1.81M derived: sum of 3 quarters · filed 2026-03-31 | -$9.91M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $188.42K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $5.55M derived: sum of 2 quarters · filed 2025-11-14 | -$6.16M 10-Q · filed 2025-11-14 | $1.38M derived: sum of 4 quarters · filed 2025-11-14 | |
| 2024-06-30 | $5.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$6.35M 10-Q · filed 2025-08-14 | $1.19M derived: sum of 3 quarters · filed 2025-08-14 | $627.24K derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | -$11.72M 10-Q · filed 2025-05-16 | -$4.17M derived: sum of 2 quarters · filed 2025-05-16 | -$4.74M derived: sum of 3 quarters · filed 2025-05-16 | ||
| 2023-12-31 | $7.54M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-10 | $6.98M derived: sum of 2 quarters · filed 2025-04-10 | $3.69M 10-K · filed 2025-04-10 | ||
| 2023-09-30 | -$564.37K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$3.86M 10-Q · filed 2024-11-14 | |||
| 2023-06-30 | -$3.29M 10-Q · filed 2023-10-13 | ||||
| 2022-06-30 | -$3.58M 10-Q · filed 2023-10-13 | ||||
| 2021-12-31 | -$8.83M 10-K · filed 2022-04-15 | ||||
| 2021-06-30 | -$1.67M 10-Q · filed 2021-08-16 | -$467.44K 10-Q · filed 2021-08-16 | |||
| 2020-12-31 | -$11.55M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-15 | -$14.20M derived: sum of 2 quarters · filed 2022-04-15 | -$15.68M derived: sum of 3 quarters · filed 2022-04-15 | -$19.89M 10-K · filed 2022-04-15 | |
| 2020-09-30 | -$2.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$4.13M derived: sum of 2 quarters · filed 2021-08-16 | -$8.34M 10-Q · filed 2020-11-12 | ||
| 2020-06-30 | -$1.47M 10-Q · filed 2021-08-16 | -$5.69M 10-Q · filed 2021-08-16 | -$5.74M 10-Q · filed 2020-08-19 | ||
| 2020-03-31 | -$4.21M 10-Q · filed 2020-06-29 | ||||
| 2019-09-30 | -$9.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$10.00M derived: sum of 2 quarters · filed 2020-11-12 | -$11.14M 10-Q · filed 2020-11-12 | ||
| 2019-06-30 | -$674.53K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-19 | -$1.82M 10-Q · filed 2020-08-19 | |||
| 2019-03-31 | -$1.14M 10-Q · filed 2020-06-29 |